About us

Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics, and therapies.

Our Commitment

Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies. As such, Sus Clinicals enables “fast cycle learning” to save clients significant time and money against a broad range of cancer therapies that can save lives and deliver commercial success.